Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 0 | 0 | 45 | 45 |
| Gross Profit | N/A | N/A | 0 | 45 | 45 |
| Operating Expenses | 15,642 | 11,584 | 11,291 | 9,844 | 7,895 |
| Operating Income | -15,642 | -11,584 | -11,291 | -9,799 | -7,850 |
| Other Income | 461 | 547 | 644 | 325 | 83 |
| Pre-tax Income | -15,181 | -11,037 | -10,647 | -9,474 | -7,767 |
| Net Income Continuous | -15,181 | -11,037 | -10,647 | -9,474 | -7,767 |
| Net Income | $-15,181 | $-11,037 | $-10,647 | $-9,474 | $-7,767 |
| EPS Basic Total Ops | -0.58 | -0.43 | -0.43 | -0.38 | -0.33 |
| EPS Basic Continuous Ops | -0.58 | -0.43 | -0.43 | -0.38 | -0.33 |
| EPS Diluted Total Ops | -0.58 | -0.43 | -0.43 | -0.38 | -0.33 |
| EPS Diluted Continuous Ops | -0.58 | -0.43 | -0.43 | -0.38 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.43 | -0.42 | -0.38 | N/A |
| EBITDA(a) | $-15,433 | $-11,402 | $-11,130 | $-9,578 | $-7,670 |